The Medford Providence Cancer Center is unveiling its new high-dose-rate (HDR) suite for patients this week for brachytherapy ...
The dedicated room ends years of scheduling bottlenecks and improves privacy for patients receiving internal radiation.
Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. | Genmab has shed another ...
PCOS and menopause can impact more than periods. Gynaecologist Dr Preetinder Kaur Bedi shares the long-term effects on ...
On this first World Cervical Cancer Elimination Day 2025, established after the World Health Assembly this year adopted a resolution to eliminate cancer of the uterine cervix as a public health ...
Life expectancy "was significantly shorter", particularly among those with severe learning disability or Down's syndrome, and ...
The FDA removed black box warnings from the treatment. Here's how the therapy containing estrogen and progesterone initially ...
Preclinical data with TK-6302 has shown best-in-class anti-tumor efficacy, demonstrating its potential to elicit deep and ...
The social media trend ‘menstrual masking’ claims period blood can rejuvenate skin. Some call it spiritual, others ...
Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025Multiple abstracts and a corporate workshop highlight Idylla™’s growing role in oncology diagnostics Itasca, IL, United States, 14 ...
AbbVie (NYSE: ABBV) announced today that a new 6-month 45mg LUPRON DEPOT® (leuprolide acetate for extended-release injectable suspension) strength has received ...
Kentuckians told the Lantern they got intrauterine devices, better known as IUDs, because of concern that they would lose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback